Founded on September 2nd, 2016, China Liver Health (CLH) is a national social service organization with independent legal person status approved by the Ministry of Civil Affairs of China （MCA）.
In December 2021, CLH was recognized as an AAA-level national social organization by MCA.
In January 2023, the Ministry of Finance, the State Administration of Taxation, and the Ministry of Civil Affairs included CLH in the “Qualified List for Pre-tax Deduction of Donations to Social Organizations for Public Welfare” for 2022-2024.
As the only national social service organization in the field of liver health in China, CLH builds a cooperation platform for relevant experts, institutions, and specialists to carry out public welfare activities and jointly contribute to raising public awareness of liver health, promoting prevention and standardized treatment of liver disease, reducing the burden of disease and eliminating social discrimination against hepatitis patients.
Lecture Tours on Fatty Liver Disease (2022 - Now)：Promoting Academic Exchange on Fatty Liver Prevention and Treatment >>
Beijing Summit Seminars on HEV Prevention and Control (2022 - Now)：HEV Prevention and Control Colloquium Series >>
Linghang Project on Observations and Treatments for CHB diseases (2022-present)：Observation of HBeAg-negative Chronic Hepatitis B in The Indeterminate Period >>
China Hepatitis D Virus Registry (2022-Now)：Follow up Chinese Patients with Hepatitis D >>
Ganquan Project on HCV Screening and Treatment (2022-Now)：Promotion of Mass Hepatitis C Prevention, Testing, and Treatment >>
STARHB Project on Hepatitis B Clinical Cure (2022-Now)：Promoting Clinical Cure for Inactive HBeAg-Negative Chronic Hepatitis B >>
Ganlin Program on HCC Early Screening (2021-Now)：Promoting Early Detection of Liver Cancer in People at High Risk >>
Collaboration Program on In-Hospital HCV Screening (2021-Now) ：Helping to Manage Hepatitis C Screening Within Hospitals >>
Extensions of Liver Health Demonstration Project (2020-Now)：Jointly with China CDCs Promoting Hepatitis B Prevention, Control, and Vaccination >>
Liver Health Demonstration Project sponsored by the National Foud (2019-2022)：Protecting Tibetan Children from Hepatitis >>
China Fatty Liver Center Academic Exchange Series (2019-Now)：Promote academic exchanges in the field of fatty liver >>
CLH Hepatitis C Elimination Programs (2017-Now)：Jointly with Experts and Institutions Across China Pushing HCV Elimination >>
Led by the comprehensive CPC committee of the social organization of MCA, China Liver Health, the Bethune Spiritual Research Association and the Tiannuo Charity Foundation jointly established "United CPC Branch of Medical Humanities and Public Welfare".
Mr. Shen Yingsheng, Deputy Director of CLH (China Liver Health) and Secretary of the Medical Humanities Public Welfare Party Branch, is also the spokesperson of the Center.
1) Coordinate and guide the preparation and implementation of the press.
2) Review news release proposals, scripts, and news Q&A.
3) Host of the press conference.
4) On behalf of the Center to release news, statements, and relevant important information to the public.
Expert team/partner hospitals
The State supported Demonstration Project of "Liver Health Promotion"
- Liver Health Promotion Expert Group ＞see who
- Hepatitis B Prevention and Control Expert Group ＞see who
- Expert consultants on maternal and child liver health promotion actions ＞see who
Hepatitis C Elimination Public Welfare Project
- Cooperative health institutions ＞see who
Early screening Project of high-risk groups of CA
- Co-built institutions ＞see who
More projects ＞see who
In recent decades, China has made remarkable achievements in public health. However, various liver diseases still seriously threaten the public health, including infectious diseases caused by viruses such as hepatitis B and hepatitis C and chronic diseases closely related to poor lifestyles such as fatty liver and alcoholic liver. Liver diseases have caused a substantial social burden, with many patients suffering from poverty due to the disease. Some patients also suffer from serious psychological problems due to social discrimination.
Prevention and control of liver disease is a social system project, which includes not only the main medical battlefield of scientific immunization and standardized treatment but also the battlefield of science education for health promotion to the public and the battlefield of public welfare assistance for the elderly, the young, the poor, the sick and the infected. For this reason, Professor Zhuang Hui, a famous hepatologist of Peking University School Health Science Center, the main promoter of hepatitis B vaccination for newborns in China, an Academician of the Chinese Academy of Engineering, initiated the organization to unite experts, volunteers, and institutions in science popularization, health education, immunization prevention, medical diagnosis and treatment, rehabilitation management and charity relief to carry out liver health promotion work together.
(i) Liver health promotion activities for the masses. Work in concert with medical schools, professional associations, foundations, research institutes, medical institutions, and pharmaceutical companies.
(ii) Matching the needs of doctors, patients, and medical institutions. Organize and mobilize volunteers in the media, education, medical care, and relief fields to carry out liver health science education, training and exchange, immunization prevention, patient rehabilitation, public assistance, and media promotion.
(iii) Promote scientific research on the prevention, treatment, and rehabilitation of liver disease at the grassroots level. Under the guidance of authoritative liver disease experts, carry out professional training and technical consultation, strengthen academic exchanges, and promote international cooperation.
(iv) Collaborate with medical institutions and experts to deliver patient services. To establish a sustainable patient management system, provide patient education, patient follow-up, treatment tracking, and other services through online and offline approaches.
(v) Under the guidance of the Ministry of Civil Affairs, the National Health Commission, the National Administration of Disease Prevention and Control, and the World Health Organization, CLH carry out policy advocacy and undertake international and domestic projects and issues.
Add: Rm 1818, Bldg 1，No. 6 Dacheng Road, Fengtai District, Beijing，China （Zip code: 100141）
Tel: 86 10-57158696